Fresenius Medical Care AG & Co. KGaA (F:FMEA) — Stock Price
Fresenius Medical Care AG & Co. KGaA (F:FMEA) is currently trading at €19.40 EUR, down 1.52% today. Over the past 52 weeks, shares have ranged between €17.70 and €23.60. This page tracks Fresenius Medical Care AG & Co. KGaA's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market cap of Fresenius Medical Care AG & Co. KGaA.
Fresenius Medical Care AG & Co. KGaA (FMEA) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Fresenius Medical Care AG & Co. KGaA's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
Fresenius Medical Care AG & Co. KGaA Income Statement — Revenue, Profit & Earnings by Year
Fresenius Medical Care AG & Co. KGaA's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | €19.63 Billion | €19.34 Billion | €19.45 Billion | €19.40 Billion | €17.62 Billion |
| Cost of Revenue | €14.60 Billion | €14.58 Billion | €14.53 Billion | €14.09 Billion | €12.54 Billion |
| Gross Profit | €5.03 Billion | €4.76 Billion | €4.93 Billion | €5.31 Billion | €5.08 Billion |
| Research & Development | €157.97 Million | €183.49 Million | €231.97 Million | €229.00 Million | €221.00 Million |
| SG&A | €3.03 Billion | €3.14 Billion | €3.20 Billion | €3.78 Billion | €3.10 Billion |
| Total Operating Expenses | €17.80 Billion | €17.87 Billion | €17.98 Billion | €18.10 Billion | €15.86 Billion |
| Operating Income | €1.83 Billion | €1.47 Billion | €1.48 Billion | €1.30 Billion | €1.76 Billion |
| EBITDA | — | — | — | €1.58 Billion | €1.93 Billion |
| EBIT | — | — | — | €1.58 Billion | €1.85 Billion |
| Interest Expense | €384.41 Million | €407.04 Million | €424.64 Million | €360.00 Million | €353.60 Million |
| Income Before Tax | €1.51 Billion | €1.06 Billion | €1.03 Billion | €1.22 Billion | €1.57 Billion |
| Income Tax Expense | — | — | — | €324.95 Million | €352.83 Million |
| Net Income | €978.37 Million | €537.91 Million | €499.00 Million | €673.00 Million | €969.00 Million |
Fresenius Medical Care AG & Co. KGaA Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Fresenius Medical Care AG & Co. KGaA's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | €31.00 Billion | €33.57 Billion | €33.93 Billion | €35.75 Billion | €34.37 Billion |
| Total Current Assets | €7.90 Billion | €7.92 Billion | €8.70 Billion | €8.20 Billion | €7.97 Billion |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | €238.77 Million | €295.63 Million | €136.29 Million | €169.98 Million | €136.36 Million |
| Net Receivables | €3.16 Billion | €3.40 Billion | €3.43 Billion | €3.67 Billion | €3.51 Billion |
| Inventory | €2.14 Billion | €2.07 Billion | €2.18 Billion | €2.30 Billion | €2.04 Billion |
| Property, Plant & Equipment | — | — | — | €8.34 Billion | €8.55 Billion |
| Goodwill | €13.57 Billion | €15.17 Billion | €14.65 Billion | €15.79 Billion | €14.36 Billion |
| Total Liabilities | €16.72 Billion | €17.80 Billion | €19.10 Billion | €20.30 Billion | €20.39 Billion |
| Total Current Liabilities | €6.25 Billion | €5.66 Billion | €6.11 Billion | €6.47 Billion | €7.26 Billion |
| Long-term Debt | €5.69 Billion | €6.26 Billion | €6.96 Billion | €7.17 Billion | €6.65 Billion |
| Net Debt | €5.72 Billion | €5.69 Billion | €6.50 Billion | €7.26 Billion | €8.57 Billion |
| Total Stockholder Equity | €13.31 Billion | €14.58 Billion | €13.62 Billion | €15.45 Billion | €13.98 Billion |
| Retained Earnings | €12.21 Billion | €11.27 Billion | €10.92 Billion | €10.71 Billion | €10.83 Billion |
Fresenius Medical Care AG & Co. KGaA Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Fresenius Medical Care AG & Co. KGaA generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | €2.68 Billion | €2.39 Billion | €2.63 Billion | €2.17 Billion | €2.49 Billion |
| Capital Expenditures | €915.37 Million | €699.36 Million | €684.60 Million | €723.99 Million | €854.36 Million |
| Free Cash Flow | €1.77 Billion | €1.69 Billion | €1.94 Billion | €756.00 Million | €806.00 Million |
| Investing Cash Flow | — | — | — | €-734.73 Million | €-1.20 Billion |
| Financing Cash Flow | €-1.40 Billion | €-2.57 Billion | €-1.86 Billion | €-1.62 Billion | €-1.02 Billion |
| Dividends Paid | €422.51 Million | €349.16 Million | €328.62 Million | €395.56 Million | €392.45 Million |
| Stock-Based Compensation | — | — | — | — | €0.00 |
| Depreciation | €1.50 Billion | €1.74 Billion | €1.75 Billion | €1.66 Billion | €1.54 Billion |
| Change in Cash | €413.79 Million | €-241.90 Million | €153.44 Million | €-207.87 Million | €400.12 Million |
Fresenius Medical Care AG & Co. KGaA Earnings History — EPS Actual vs. Analyst Estimates
Track Fresenius Medical Care AG & Co. KGaA's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 05, 2026 | — | 0.50 | — |
| Feb 24, 2026 | — | 0.55 | — |
| Nov 04, 2025 | — | 0.50 | — |
| Aug 05, 2025 | — | — | — |
| May 06, 2025 | — | — | — |
| Feb 25, 2025 | — | — | — |
| Nov 05, 2024 | — | — | — |
| Jun 30, 2023 | 0.24 | — | — |